Frontlight ResearchEarly access
Trial site
Hospital Universiti Sains Malaysia
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes2 trials
- Depression1 trial
- Glaucoma1 trial
- Head and neck cancer1 trial
- High blood pressure1 trial
- Irritable bowel syndrome1 trial
- Melanoma1 trial
- Stroke1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 33 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Hospital Universiti Sains Malaysia2 trials
- Universiti Sains Malaysia2 trials
- Amgen1 trial
- Eli Lilly and Company1 trial
- EP Plus Group Sdn Bhd1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Glaucoma1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes
Completed
Stingless Bee Honey Augmentation in Major Depressive Disorders
Completed
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Completed
Completed
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
Site data: ClinicalTrials.govUpdated 13 Nov 2026